Guidelines: Intitut National du Cancer Guidelines (Luxembourg): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 71: | Line 71: | ||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | ||
<span style="display:none">isPracticeGuideline</span> | <span style="display:none">isPracticeGuideline</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
Revision as of 11:23, 6 December 2025
Go back to Luxembourg page
Primary purpose: To provide recommendations for the treatment of various types of cancers.
Sponsor, manager or home institution: Intitut National du Cancer; Conseil Scientifique Domaine de la Santé.
Type of information: Recommendations, treatments, supportive care and follow up of colorectal cancer, gynecological cancer, breast cancer, pancreatic cancer, cutaneous malignant melanomas, hematological cancers, brain and central nervous system cancer. Click here to learn more.
Cancer areas of interest: C15-C26: Digestive system cancers; C30-C39: Lung/chest cancers; C43-C44: Skin cancers/melanoma; C50: Breast cancer; C51-C58: Female genitalia cancer; C69-C72: Eye and brain cancer; C81-C96: Cancers of the blood and immune system; C60-C63: Male genitalia cancer. Click here to learn more.
Access to information: Click here to access.